Veracyte Has Released Our Inaugural ESG Report READ NOW
Search Tool Menu
Veracyte Has Released Our Inaugural ESG Report READ NOW
Menu
Close Button

Accelerating Answers,
Improving Outcomes

Veracyte is committed to transforming patient care in cancer and other diseases. At every step of the patient journey, we are innovating to prevent unnecessary interventions and accelerate time to appropriate treatment.

Learn more about Veracyte’s products

Thyroid Cancer

Reducing unnecessary surgeries and informing treatment decisions in thyroid cancer diagnosis

Learn More >

Prostate Cancer

Providing clarity and confidence in treatment planning

Learn More >

Breast Cancer

Using prognostic information to inform next steps in patient care

Learn More >

Lung Cancer

Providing answers at every step of the patient journey

Learn More >

ILD

Improving ILD diagnosis and confidence in treatment decisions

Learn More >

Bladder Cancer

Revealing cancer molecular subtype to inform treatment decisions

Learn More >